Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/article/10.1007/s00432-018-2580-1/fulltext.html
Reference48 articles.
1. Alaggio R, Turrini R, Boldrin D, Merlo A, Gambini C, Ferrari A, Dall’igna P, Coffin CM, Martines A, Bonaldi L, De Salvo GL, Zanovello P, Rosalo A (2013) Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). PLoS One 8:E80456
2. Anborgh PH, Mutrie JC, Tuck AB, Chambers AF (2011) Pre- and post- translational regulation of osteopontin in cancer. J Cell Commun Signal 5:111–122
3. Bache M, Kappler M, Wichmann H, Rot S, Hahnel A, Greither T, Said HM, Kotzsch M, Wurl P, Taubert H, Vordemark D (2010) Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients. BMC Cancer 10:132
4. Brady SW, Zhang J, Tsai MH, Yu D (2015) PI3K-independent mTOR activation promotes lapatinib resistance and IAP expression that can be effectively reversed by mTOR and Hsp90 inhibition. Cancer Biol Ther 16:402–411
5. Bramwell VH, Tuck AB, Wilson SM, Stitt LW, Cherian AK, Rorke SC, Al-Katib W, Postenka CO, Chambers AF (2005) Expression of osteopontin and HGF/met in adult soft tissue tumors. Cancer Biol Ther 4:1336–1341
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs;Oncogene;2024-03-13
2. Malignant peripheral nerve sheath tumor — from genetics to multidisciplinary treatment;Oncology in Clinical Practice;2024-02-27
3. p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs;2023-06-26
4. p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs;2023-01-19
5. YM155 and chrysin cooperatively suppress survivin expression in SMARCB1/INI1-deficient tumor cells;Medical Oncology;2022-09-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3